Benzinga | Aug 12, 2021 04:24PM EDT

Lineage Cell Therapeutics Q2 EPS $(0.03) Beats $(0.04) Estimate, Sales $500.00K Beat $480.00K Estimate

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 25 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $500.00 thousand which beat the analyst consensus estimate of $480.00 thousand by 4.17 percent. This is a 29.53 percent increase over sales of $386.00 thousand the same period last year.